Reduces risk of cardiovascular events: People who use Semaglutide are less likely to have strokes and heart attacks than those who dont use it
They understand half-lives, dosing protocols, and stacking strategies
Mechanistic work probing how the Aib substitution at position 8 contributes to DPP-4 resistance compared with native GLP-1, where targeted residue substitution can be examined for its effect on enzymatic stability and receptor engagement
Walking 7,000 to 10,000 steps daily is an achievable, sustainable cardiovascular goal for most patients
An additional 202 articles were excluded for the following reasons: irrelevant study population (n=60), unrelated interventions (n=90), insufficient or incomplete data (n=52), and language limitations (non-English)